SIG.AX

Sigma Healthcare Limited
ASXAUDEQUITY Healthcare DELAYED
Last price
2.90
■ 0.00 (0.00%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
2.90
Day high
2.92
Day low
2.88
Volume
6.87M
Market cap
$33.48B
P/E (TTM)
58.00
52W range
2.58 – 3.20

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-2.68% -1.3%
1M
+1.05% -2.7%
3M
+1.75% -1.3%
6M
-2.36% -13.4%
YTD
-1.36% -13.6%
1Y
+0.69% -19.3%
3Y
+280.78% +206.6%
5Y
+382.12%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on SIG.AX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
6.39B
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Nov 10, 25
Carey (Annette)
Independent Non-Executive Director
BUY 10.00K $20.41K Direct
Aug 28, 25
Gance (Jack)
Director (Non-Executive)
SELL 155.10M $313.98M Direct
Jun 30, 25
Davis (Mark)
Chief Financial Officer
2.70M Direct
Jun 30, 25
Spargo (Kathryn Dianne)
Former
719.68K Direct
May 29, 25
Pilla (Danielle Di)
Director (Executive)
SELL 7.34M $15.02M Direct
May 28, 25
Pilla (Danielle Di)
Director (Executive)
SELL 7.50M $15.42M Direct
May 27, 25
Pilla (Danielle Di)
Director (Executive)
SELL 14.76M $30.03M Direct
May 26, 25
Pilla (Danielle Di)
Director (Executive)
SELL 235.35K $480.60K Direct
May 9, 25
Gance (Damien)
Director (Non-Executive)
SELL 126.50M $244.92M Direct
Apr 14, 25
Gance (Damien)
Director (Non-Executive)
SELL 100.00M $187.85M Direct
Feb 14, 25
Gance (Damien)
Director (Non-Executive)
SELL 40.00M $76.20M Direct
Feb 14, 25
Ramsunder (Vikesh)
Chief Executive Officer
3.13M Direct
Feb 13, 25
Ramsunder (Vikesh)
Chief Executive Officer
11.66M Direct
Feb 12, 25
Pilla (Danielle Di)
Director (Executive)
105.47M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

8 reporting
NameRelationShares heldLatest
Carey (Annette)
Independent Non-Executive Director 31.21K Purchase
Davis (Mark)
Chief Financial Officer 2.70M Other
Gance (Damien)
Director (Non-Executive) 133.74M Sale
Gance (Jack)
Director (Non-Executive) 1.42B Sale
Pilla (Danielle Di)
Director (Executive) 75.63M Sale
Ramsunder (Vikesh)
Chief Executive Officer 3.13M Other
Spargo (Kathryn Dianne)
Former 0 Other
Verrocchi (Mario)
Divisional Officer 2.56B Other

Fundamentals

TTM · reported
Market cap$33.48B
Enterprise value$35.19B
Revenue (TTM)$9.55B
Gross profit$1.77B
EBITDA$933.20M
Net income$599.81M
EPS (TTM)$0.05
Free cash flow
Total cash$160.54M
Total debt$2.00B
Book value / share$0.43
Shares outstanding11.54B
Float6.47B
Short % of float
Dividend yield1.38%
Beta (5Y)0.34

Valuation & profitability ratios

Account required
Trailing P/E58.00
Forward P/E37.91
PEG ratio4.83
Price / sales
Price / book6.81
EV / revenue3.69
EV / EBITDA37.71
Gross margin18.55%
Operating margin9.76%
Profit margin6.28%
Return on equity
Return on assets
Debt / equity40.95
Current ratio1.67
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 1 quarters
Blank means not reported, not zero
Line item202520242023YoY
Total revenue $6.00B$3.38B$3.66B +77.8%
Operating revenue $6.00B$3.38B$3.66B +77.8%
Cost of revenue $4.56B$3.10B$3.41B +47.0%
Gross profit $1.44B$271.85M$254.41M +429.8%
Selling, general & admin $717.70M$261.77M$293.00M +174.2%
Total operating expense $773.68M$290.09M$329.82M +166.7%
Operating income $666.61M-$18.24M-$75.41M +3,754.6%
Net interest income -$24.39M-$14.58M-$13.81M -67.3%
Pre-tax income $743.49M$8.62M$5.46M +8,521.2%
Tax provision $218.04M$3.31M$2.44M +6,481.3%
Net income $529.91M$4.51M$1.81M +11,652.4%
Net income to common $529.91M$4.51M$1.81M +11,652.4%
Basic EPS 0.050.000.00 +1,059.1%
Diluted EPS 0.050.000.00 +1,059.1%
EBIT $776.61M$24.93M$19.87M +3,015.5%
EBITDA $832.59M$53.25M$50.20M +1,463.5%
Basic shares 10.48B1.02B1.02B +922.8%
Diluted shares 10.48B1.02B1.02B +922.8%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 0.06 15 $10.88B +81.3%
Next year 0.08 15 $12.08B +11.0%

Analyst targets & ownership

Account required
Mean target$3.30
High target$3.90
Low target$2.60
Implied upside13.84%
Analyst count16
ConsensusBUY
Strong buy / Buy3 / 8
Hold5
Sell / Strong sell0 / 0
Held by insiders55.58%
Held by institutions10.28%
Institutions holding219
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
2.94
-1.36% from price
SMA 20
2.95
-1.58% from price
SMA 50
2.87
+0.88% from price
SMA 100
2.84
+2.02% from price
SMA 200
2.87
+0.89% from price
EMA 12
2.93
-1.05% from price
EMA 26
2.92
-0.79% from price
EMA 50
2.90
+0.10% from price
RSI (14)
45.4
Neutral
MACD (12,26,9)
0.01
Hist -0.01
ATR (14)
0.04
1.43% of price
Realised vol 30D
16.4%
Annualised
Bollinger upper
3.02
20, 2σ
Bollinger lower
2.87
20, 2σ
50 / 200 cross
Golden
2.87 vs 2.87
Trend bias
Above 200
+0.89%

Options chain

Account required
ExpirySpot 2.90
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.31
Less volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
16.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-17.7%
Peak to trough
Max drawdown 5Y
-33.8%
Peak to trough
ATR 14
0.04
1.43% of price
Beta (reported)
0.34
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$0.04 / yr
Forward yield1.38%
5-year avg yield1.55%
Payout ratio0.00%
Ex-dividend dateMar 4, 2026
Next pay date
Last split1.0418:1
Split dateSep 10, 2009

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.